tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Kazia Therapeutics files to sell 232,956 American Depositary Shares for holders
PremiumThe FlyKazia Therapeutics files to sell 232,956 American Depositary Shares for holders
10d ago
Two new option listings and nine option delistings on September 22nd
Premium
The Fly
Two new option listings and nine option delistings on September 22nd
18d ago
Buy Rating for Kazia Therapeutics Driven by Promising Paxalisib Developments in Cancer Treatment
Premium
Ratings
Buy Rating for Kazia Therapeutics Driven by Promising Paxalisib Developments in Cancer Treatment
27d ago
Kazia Therapeutics Announces At the Market Offering Agreement
PremiumCompany AnnouncementsKazia Therapeutics Announces At the Market Offering Agreement
3M ago
Promising Clinical Developments and Financial Adjustments Drive Buy Rating for Kazia Therapeutics
Premium
Ratings
Promising Clinical Developments and Financial Adjustments Drive Buy Rating for Kazia Therapeutics
3M ago
Kazia Therapeutics target adjusted to $13 from $2 at H.C. Wainwright
Premium
The Fly
Kazia Therapeutics target adjusted to $13 from $2 at H.C. Wainwright
3M ago
Buy Rating for Kazia Therapeutics Driven by Promising Paxalisib Data and Strategic Developments
PremiumRatingsBuy Rating for Kazia Therapeutics Driven by Promising Paxalisib Data and Strategic Developments
4M ago
Kazia Therapeutics Unveils Promising Preclinical Data for Paxalisib in Breast Cancer
Premium
Company Announcements
Kazia Therapeutics Unveils Promising Preclinical Data for Paxalisib in Breast Cancer
4M ago
Kazia Therapeutics trading resumes
Premium
The Fly
Kazia Therapeutics trading resumes
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100